Asthma and COPD Drugs (Izard) Flashcards
What are the two goals of asthma therapy?
Reduction in impairment
Reduction in risk
Most widely used drug class in asthma/COPD treatment?
Beta-2 receptor agonists
Primary action of Beta-2 agonists
Relax airway smooth-muscle cells of all airways
Albuterol class?
Short acting beta agonist (SABA)
Albuterol contraindications/warnings?
Paradoxical bronchospasm
CV effects
Terbutaline class?
SABA with preferential effects on the beta-2 receptors
Terbutaline uniqueness?
Only beta-2 drug available by subQ injection.
Can’t give in patients with sulfa allergy
Age approved in use of terbutaline?
12
Metaproterenol class?
SABA
Metaproterenol indication?
bronchial asthma and reversible bronchospasm
Metaproterenol warnings?
paradoxical bronchospasm
Pirbuterol class?
SABA
Pirbuterol indication? Age?
prevention and reversal of bronchospasm in patients 12 and older
Pirbuterol cautions?
can produce a clinically significant CV effect
Levalbuterol class?
SABA
Levalbuterol indication?
treatment or prevention of bronchospasm
Levalbuterol age?
4 years or older
Levalbuterol caution/warning?
Paradoxical bronchospasm
Beclomethasone class?
ICS
Beclomethasone indication? Age?
maintenance/treatment of asthma and as prophylactic therapy in patients 5 and older
Beclomethasone cautions/warnings?
Deaths due to adrenal insufficiency have occured in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids .
Several months are required for recovery of HPA function
Most effective class for controlling asthma?
ICS
Which cells to ICS remove in the airway?
Eosinophils, Mast cells, and T lymphocytes
Major effect of corticosteroids in asthma?
switch off the transcription of multiple activated genes that encode inflammatory proteins
ICS dosing?
twice daily
If ICS does not control asthma, what is the next step?
LABA
Budesonide class?
ICS
Budesonide indication? Age?
Maintenance treatment of asthma as prophylactic therapy in patients 6 years and older
Budesonide caution/warning?
Should not be used where primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.
Ciclesonide class?
ICS
Ciclesonide indication? Age?
Maintenance treatment of asthma as prophylactic therapy in patients 12 years and older
Ciclesonide cautions/warnings?
Not indicated for Asthma attacks
Use not recommended when patient has presence of Candida albicans infection of mouth/pharynx
Flunisolide class?
ICS
Flunisolide indication? Age
Maintenance treatment of asthma as prophylactic therapy in patients 6 years and older.
Asthma patients requiring oral corticosteroid therapy, where adding flunisolide therapy may reduce or eliminate the need
Fluticasone class?
ICS
Fluticasone indication? Age?
Maintenance treatment of asthma as prophylactic therapy in patients 4 and older.
Fluticasone cautions
Candida albicans infection of the mouth and pharynx may occur.
Mometasone class?
ICS
Mometasone indication? Age?
Asthma as prophylactic therapy in patients 4 and older.
Mometasone cautions?
hypersensitivity to milk proteins
Triamcinolone class?
ICS
Triamcinolone indications?
Asthma
Patients who require systemic corticosteroid administration, where adding this agent may reduce or eliminate the need for the systemic corticosteroids
Triamcinolone cautions?
Status asthmaticus or other acute episodes of asthma where intensive measures are required.
Care is needed in patients who are transferred from systemically active corticosteroids to Triamcinolone because deaths due to adrenal insufficiency have occurred.
Oral and parenteral corticosteroid uses?
used in combination with SABAs to treat moderate to sever asthma flare-ups.
More likely to cause side effects
Prednisone class?
OCS
Prednisone indication?
Anti-inflammatory or immunosuppressive agent
treatment of certain endocrine conditions
Prednisone cautions?
Adrenal Insufficiency
May lead to HPA axis suppression
Fomoterol class?
LABA
Fomoterol indication? Age?
Add on to an inhaled corticosteroid in asthma patients >5 yeras old.
COPD maintenance
Fomoterol Contraindications?
LABAs increase risk of asthma-related deaths and asthma related hospitalizations, must use with use of a long-term asthma control medication.
Salmeterol class?
LABA
Salmeterol indication? Age?
exercise-induced bronchospasm in patients aged 4 and older.
COPD maintenance
Indaceterol and Vilanterol class?
LABAs
Indaceterol and Vilanterol indication?
breathing problems caused by COPD
Olodaterol class?
LABA
Olodaterol indication?
chronic bronchitis
emphysema
Used in the long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients
MOA for anticholinergic drugs?
block acetylcholine from binding to its receptors on certain nerve cells.
Inhibit parasympathetic nerve impulses
anti-muscarinic agents most widely used in asthma/COPD
Atropine class?
anticholinergic
Atropine indication?
temporary blockade of severe or life threatening muscarinic effects.
Atropine cautions?
atropine-induced tachycardia
Increased myocardial oxygen demand.
total dose should be restricted to 2 to 3 mg to avoid detrimental effects
Ipratropium class?
anticholinergic
Ipratropium indicaiton?
maintenance treatment of bronchospasm
poorly absorbed after aerosol administration and is therefore relatively free of systemic atropine-like effects
Tiotropium class?
anticholinergic
Tiotropium indication?
long-term, once-daily, maintenance treatment of bronchospasm
Aclidinium class?
Anticholinergic
Aclidinium indication?
long-term maintenance treatment of bronchospasm associated with COPD
Theophyline class?
Methylxanthine
Theophylline MOA?
Smooth muscle relaxation
suppression of the response of the airways to stimuli
Theophylline cautions?
use extreme caution in patients with:
active peptic ulcer disease
seizure disorders
cardiac arrhythmias
Leukotriene antagonist MOA?
Block cysteinyl leukotriene receptors and blocking their subsequent inflammatory cascade
Montelukast class
Leukotriene antagonist
Montelukast MOA
inhibit LTD4 at the CysLT1 receptor without any agonist activity
Montelukast indications
allergies and prevent asthma attacks
Montelukast cautions
Can’t use in acute asthma attacks
Zafirlukast class?
Leukotriene antagonist
Zafirlukast MOA?
selective and competitive receptor antagonist of Leukotriene D4 and E4
Zafirlukast indication? Age?
Prophylaxis and chronic treatment of asthma in patients 5 years and older
Zafirlukast caution?
Hepatotoxicity
Zileuton MOA?
inhibitor of 5-lipoxygenase and thus inhibits LTB4, C4, D4, and E4 formation
Is zileuton IR or ER?
ER
Zileuton indication? Age?
Prophylaxis and chronic treatment of asthma in patients 12 years and older
Zileuton caution
Active liver disease/ liver enzymes 3x upper limit
Omalizumab class
Monoclonal antibody
Omalizumab MOA/indication?
anti-IgE antibody indicated for moderate to severe persistent asthma in patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen.
Chronic idiopathic urticaria in patients 12 years and older if h1 antihistamine treatment isn’t working.
Omalizumab caution
Anaphylaxis